Optic Neuritis in the New Millennium-Reference-Cited by-同舟云学术

Optic Neuritis in the New Millennium

Published:2024-04 Issue:2 Volume:62 Page:137-147
ISSN:2589-4528
Container-title:TNOA Journal of Ophthalmic Science and Research
language:en
Short-container-title:

Author:

Hoffman Clarissa M.¹,Tang Rui²,Alryalat Saif A.³⁴,Al Deyabat Osama³,Alchaki Abdul R.⁵,Lee Andrew G.³⁶⁷⁸⁹

Affiliation:

1. University of Texas Health Science Center, Houston, Texas, USA

2. Paul L. Foster School of Medicine, Texas Tech University Health Science Center, El Paso, Texas, USA

3. Department of Ophthalmology, Blanton Eye Institute, Houston Methodist Hospital, Houston, Texas, USA

4. Department of Ophthalmology, The University of Jordan, Amman, Jordan

5. Department of Neurology, Houston Methodist Hospital, Houston, Texas, USA

6. Department of Ophthalmology, Cullen Eye Institute, Baylor College of Medicine, Houston, Texas, USA

7. Departments of Ophthalmology, Neurology, and Neurosurgery, Weill Cornell Medicine, New York, USA

8. Department of Ophthalmology, University of Texas MD Anderson Cancer Center, Houston, Texas, USA

9. Texas A and M College of Medicine, Bryan, Texas, USA

Abstract

Abstract Optic neuritis (ON) is a common cause of acute visual loss due to optic neuropathy in adults. Although typical demyelinating ON usually recovers, some forms of autoimmune inflammatory ON may result in permanent disability. The relatively recent discovery of novel autoantibodies and their roles in the pathogenesis of ON, including aquaporin 4 (AQP4) in neuromyelitis optica spectrum disorders (NMOSD) and myelin oligodendrocyte glycoprotein (MOG) antibody in MOG-associated disease (MOGAD) has led to paradigm shifts in both the acute and chronic management of ON. We performed a comprehensive literature review to assess current and upcoming perspectives on ON by searching for contemporary articles (from 2015 to 2024) for articles that reported updates in diagnostic tools and methods, such as antibody testing. This monograph reviews these recent advances in the evaluation and management of ON.

Publisher

Medknow

Reference123 articles.

1. A serum autoantibody marker of neuromyelitis optica:Distinction from multiple sclerosis;Lennon;Lancet,2004

2. Critical review:Typical and atypical optic neuritis;Abel;Surv Ophthalmol,2019

3. Optic neuritis as an early sign of multiple sclerosis;Kale;Eye Brain,2016

4. The epidemiology of multiple sclerosis:Insights to a causal cascade;Goodin;Handb Clin Neurol,2016

5. Rising prevalence of multiple sclerosis worldwide:Insights from the Atlas of MS, third edition;Walton;Mult Scler,2020